142 related articles for article (PubMed ID: 28927043)
1. Expression of P-EGFR and P-Akt protein in esophageal squamous cell carcinoma and its prognosis.
Shan ZZ; Chen PN; Wang F; Wang J; Fan QX
Oncol Lett; 2017 Sep; 14(3):2859-2863. PubMed ID: 28927043
[TBL] [Abstract][Full Text] [Related]
2. Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas.
Yang YL; Xu KL; Zhou Y; Gao X; Chen LR
Chin Med J (Engl); 2012 Feb; 125(3):450-4. PubMed ID: 22490401
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of periostin and EGFR in patients with esophageal squamous cell carcinoma and their prognostic significance.
Jia W; Wang W; Ji CS; Niu JY; Lv YJ; Zhou HC; Hu B
Onco Targets Ther; 2016; 9():5133-42. PubMed ID: 27574454
[TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients.
Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z
Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836
[TBL] [Abstract][Full Text] [Related]
7. [Effects of microRNA-182-5p on cell proliferation and invasion of esophageal squamous cell carcinoma and related molecular mechanisms].
Zhu ZQ; Hu HF; Zheng XY; Wang F
Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):635-643. PubMed ID: 32867454
[No Abstract] [Full Text] [Related]
8. Assessment of epidermal growth factor receptor mutation/copy number and K-ras mutation in esophageal cancer.
Guo K; Wang WP; Jiang T; Wang JZ; Chen Z; Li Y; Zhou YA; Li XF; Lu Q; Zhang LJ
J Thorac Dis; 2016 Jul; 8(7):1753-63. PubMed ID: 27499966
[TBL] [Abstract][Full Text] [Related]
9. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
[TBL] [Abstract][Full Text] [Related]
10. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
11. Correlation between secreted protein acidic and rich in cysteine protein expression and the prognosis of postoperative patients exhibiting esophageal squamous cell carcinoma.
Wu J; Zhang JR; Jiang XQ; Cao XG
Mol Med Rep; 2017 Sep; 16(3):3401-3406. PubMed ID: 28713937
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].
Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH
Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822
[TBL] [Abstract][Full Text] [Related]
13. [A histopathologic and immunohistochemical study of prognostic factors in esophageal squamous cell carcinoma].
Wang Y; Chen J; Meng L; Liu J; Du D; Zou Y
Zhonghua Bing Li Xue Za Zhi; 2000 Aug; 29(4):267-71. PubMed ID: 11866922
[TBL] [Abstract][Full Text] [Related]
14. The decreased expression of miR-625 predicts poor prognosis of esophageal squamous cell carcinoma.
Li C; Li DC; Che SS; Ma K; Wang YJ; Xia LH; Dai XM; Zhang GT; Shen Y; Jiao WJ; Tian KH
Int J Clin Exp Med; 2015; 8(6):9560-4. PubMed ID: 26309624
[TBL] [Abstract][Full Text] [Related]
15. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma.
Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY
Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443
[TBL] [Abstract][Full Text] [Related]
16. The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma.
Han T; Wang Z; Yang Y; Shu T; Li W; Liu D; Li P; Qi R; Ren Y; Li L; Liu H; Zhang S; Zhang L
Oncol Rep; 2015 Sep; 34(3):1353-60. PubMed ID: 26135942
[TBL] [Abstract][Full Text] [Related]
17. [Expression of FBXW7 in esophageal squamous cell carcinoma and its clinical significance].
Yu H; Ling T; Shi R; Shu Q; Li Y; Tan Z
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):347-51. PubMed ID: 26463024
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in Chinese patients with esophageal squamous cell carcinoma.
Cui Y; Dong C; Wu BQ; Duan XC; Shi G; Gong M; Wang TY
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C44-8. PubMed ID: 26323923
[TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical significance of DAPK1 and CD147 in esophageal squamous cell carcinoma].
Wan Y; Wu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):44-8. PubMed ID: 22490855
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma.
Zhu Z; Yu W; Fu X; Sun M; Wei Q; Li D; Chen H; Xiang J; Li H; Zhang Y; Zhao W; Zhao K
J Exp Clin Cancer Res; 2015 Sep; 34(1):95. PubMed ID: 26338103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
